Identità

Darifenacin Dimer-2 Impurity

Mhux elenkat · C38H40N2O3

01Identità

Lazychem IDLC-39434
CAS RNMhux elenkat
PubChem CID59622462
Molecular formulaC38H40N2O3
Molecular weight572.7 g/mol
IUPAC nameN-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
InChIKeyBHNVASHDXPOSCJ-UUWRZZSWSA-N

02Struttura u stereokimika

Two-dimensional chemical structure of Darifenacin Dimer-2 Impurity
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 7 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count7
Secondary amines0
Tertiary amines1
SMILESC1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)NCCC4=CC5=C(C=C4)OCC5)CCC6=CC7=C(C=C6)OCC7
InChIMhux elenkat

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status fl-Indja

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Ismijiet u relazzjonijiet

API u mediċina prinċipali

Mhux elenkat

Ismijiet u relazzjonijiet

    06Sorsi